Literature DB >> 11011961

Inhibition by vitamin C of DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumor cells.

H C Wu1, H F Lu, C F Hung, J G Chung.   

Abstract

Previous studies have already demonstrated the protective role of vitamin C (ascorbic acid) in certain types of cancer. This study reports on the effects of vitamin C on arylamine N-acetyltransferase (NAT) activity and DNA adduct formation in a human bladder tumor cell (T24) line. The activity of NAT was measured using high-performance liquid chromatography (HPLC), by assaying for the amounts of acetylated 2-aminofluorene (AF) and p-aminobenzoic acid (PABA) and the remaining amounts of AF and PABA. T24 cells were used for examining NAT activity and carcinogen DNA adduct formation. The results demonstrated that NAT activity and 2-aminofluorene DNA adduct formation in T24 cells were inhibited and decreased by vitamin C in a dose-dependent manner. The apparent kinetic parameters (apparent values of Km and Vmax) from T24 cells were also determined with and without vitamin C cotreatment. The data also indicated that vitamin C decreased the apparent values of Km and Vmax from T24 cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011961     DOI: 10.1007/s002400000130

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  2 in total

1.  Cadmium alters the biotransformation of carcinogenic aromatic amines by arylamine N-acetyltransferase xenobiotic-metabolizing enzymes: molecular, cellular, and in vivo studies.

Authors:  Nilusha Ragunathan; Julien Dairou; Elodie Sanfins; Florent Busi; Christophe Noll; Nathalie Janel; Jean-Marie Dupret; Fernando Rodrigues-Lima
Journal:  Environ Health Perspect       Date:  2010-09-01       Impact factor: 9.031

2.  Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials.

Authors:  So Jung Park; Seung Kwon Myung; Yunju Lee; Yong Jae Lee
Journal:  J Korean Med Sci       Date:  2017-04       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.